Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Leht 1 alates 16 tulemused
Benzamide inhibitors of the P2X7 Ereceptor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention relates to novel benzamide inhibitors of the P2X.sub.7 receptor, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, and their use in therapy. The active compounds of the present invention are useful in the
Benzamide inhibitors of the P2X.sub.7 receptor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
The present invention relates to novel benzamide inhibitors of the P2X.sub.7 receptor, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, and their use in therapy. The active compounds of the present
Benzamide inhibitors of the P2X.sub.7 receptor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
The present invention relates to novel benzamide inhibitors of the P2X.sub.7 receptor, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, and their use in therapy. The active compounds of the present
Benzamide inhibitors of the P2X.sub.7 receptor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention relates to novel benzamide inhibitors of the P2X.sub.7 receptor, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, and their use in therapy. The active compounds of the present invention are useful in the
Benzamide inhibitors of the P2X.sub.7 receptor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
The present invention relates to novel benzamide inhibitors of the P2X.sub.7 receptor, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, and their use in therapy. The active compounds of the present
Benzamide inhibitors of the P2X.sub.7 receptor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
The present invention relates to novel benzamide inhibitors of the P2X.sub.7 receptor, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, and their use in therapy. The active compounds of the present
Benzamide inhibitors of the P2X.sub.7 receptor
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
The present invention relates to novel benzamide inhibitors of the P2X.sub.7 receptor, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, and their use in therapy. The active compounds of the present
4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention relates to 4-fluoro-N-indan-2-yl benzamide of the formula (I) and its use as pharmaceutical agent.
##STR00002##
Endothelial NO synthase (eNOS, NOS-III) belongs to a group of three isoenzymes which produce nitric oxide (NO) by oxidation of arginine. Endothelially released NO is
4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention relates to 4-fluoro-N-indan-2-yl benzamide of the formula (I) and its use as pharmaceutical agent. ##STR2##
Endothelial NO synthase (eNOS, NOS-III) belongs to a group of three isoenzymes which produce nitric oxide (NO) by oxidation of arginine. Endothelially released NO is of
4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention relates to 4-fluoro-N-indan-2-yl benzamide of the formula (I) and its use as pharmaceutical agent. ##STR2##
Endothelial NO synthase (eNOS, NOS-III) belongs to a group of three isoenzymes which produce nitric oxide (NO) by oxidation of arginine. Endothelially released NO is of
N-alkyl-adamantyl triazinyl benzamide derivatives
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention relates to N-alkyl adamantyl triazinyl benzamide derivatives, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, and their use in therapy. The active compounds of the present invention are useful in the
Benzamide, heteroarylamide and reverse amides
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to novel benzamide, heteroarylamide and reverse amide, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, and their use in therapy. The active compounds of the present invention
Benzamide, heteroarylamide and reverse amides
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention relates to novel benzamide, heteroarylamide and reverse amide, processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them, and their use in therapy. The active compounds of the present invention are useful in the
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention provides benzoic acid and amide derivatives of anthranilic acids which inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer and restenosis.
BACKGROUND OF THE INVENTION
Proliferative diseases are caused by a defect in
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This invention provides benzoic acid and amide derivatives of anthranilic acids which inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer and restenosis.
BACKGROUND OF THE INVENTION
Proliferative diseases are caused by a defect in
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
